Señales en vivo de CMPX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases...

Stats
Volumen de hoy	65 665.00
Volumen promedio	375 306
Capitalización de mercado	184.85M
EPS	$0 ( 2024-03-20 )
Próxima fecha de ganancias	( $0 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.39
ATR14	$0.0120 (0.83%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-08	Boylan James P	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Gray Mary Ann	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Lindahl Richard S	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Gordon Carl L	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Chiniara Ellen	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
93.94
Last 94 transactions
Buy: 28 287 388 \| Sell: 226 920

Volumen Correlación

Largo: 0.04 (neutral)

Corto: 0.05 (neutral)

Signal:(49.093) Neutral

Compass Therapeutics, Correlación

10 Correlaciones Más Positivas
PIXY	0.935
WTBA	0.915
UPC	0.91
LLNW	0.909
GSMG	0.908
ALXO	0.905
ENNV	0.902
YJ	0.902
BMRA	0.897
LVTX	0.893

10 Correlaciones Más Negativas
HHGC	-0.937
KYCH	-0.936
UONE	-0.936
OLED	-0.931
PPD	-0.93
SIBN	-0.927
CDNS	-0.927
NVTS	-0.923
ALYA	-0.923
MELI	-0.923

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Compass Therapeutics, Correlación - Moneda/Commodity

-0.60
( weak negative )

-0.36
( neutral )

0.00
( neutral )

-0.46
( neutral )

0.00
( neutral )

0.41
( neutral )

Compass Therapeutics, Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$-1.90M (0.00 %)
EPS:	$-0.350

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-1.90M (0.00 %)
EPS:	$-0.350

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.583

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.566

Financial Reports:

No articles found.

Compass Therapeutics,

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Actualizaciones en tiempo real para Compass Therapeutics, [CMPX]

Upcoming Earnings Alert